メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Decubitus ulcer infection and bacteremia due to tazobactam/piperacillin-resistant Veillonella parvula

  • Shoko Sahara
  • , Teruhisa Kinoshita
  • , Tomomi Amano
  • , Misa Ishida
  • , Takashi Yamakita
  • , Norio Takimoto
  • , Keisuke Oka

研究成果: ジャーナルへの寄稿学術論文査読

抄録

This is the first case report of decubitus infection and bacteremia due to Veillonella parvula (V. parvula). A patient in his 70s with pre-existing diabetes mellitus was admitted with decubitus infection, and tazobactam/piperacillin treatment was initiated. Tazobactam/piperacillin-resistant V. parvula was detected in the blood and decubitus site cultures. The antimicrobial treatment was changed to clindamycin and cefmetazole. Antimicrobial therapy was administered for 28 days. The patient was transferred to a convalescent hospital. V. parvula occasionally causes infection in immunocompromised patients with underlying diseases, such as diabetes. An appropriate evaluation by culture test is important for diagnosis, treatment, and recurrence prevention. Tazobactam/piperacillin is often used in the treatment of multi-bacterial infections such as decubitus infections. V. parvula may be resistant to tazobactam/piperacillin, and this possibility should be taken into account when administering treatment.

本文言語英語
ページ(範囲)524-553
ページ数30
ジャーナルNagoya journal of medical science
86
3
DOI
出版ステータス出版済み - 2024
外部発表はい

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

All Science Journal Classification (ASJC) codes

  • 医学一般

フィンガープリント

「Decubitus ulcer infection and bacteremia due to tazobactam/piperacillin-resistant Veillonella parvula」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル